Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Journal for Immunotherapy of Cancer
|
November 19, 2025
CD28 signaling complexes are correlated with patient outcomes in anti-CD19 41BB-costimulation CAR T cell therapy
Isabella H Draper, William Selke, Samuel A Ritmeester-Loy, et al.
Transplantation and Cellular Therapy
|
September 9, 2023
INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia
Adam J Lamble, Amy Moskop, Michael A Pulsipher, et al.
Bone Marrow Transplantation
|
January 24, 2019
Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children
Ann Dahlberg, Wendy Leisenring, Marie Bleakley, et al.
Cancers
|
May 28, 2025
Disease Burden at the Time of Transplantation Is a Primary Predictor of Outcomes in Pediatric MDS: A Single-Center Experience
Ann Dahlberg, Phil Stevenson, Neel S Bhatt, et al.
JPGN Reports
|
May 11, 2023
Adjunctive Dietary Therapy Is Associated With Improved Gastrointestinal Symptoms in Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease: A Case Series
Tanyaporn Kaenkumchorn, David L Suskind, Dale Lee, et al.
Blood Advances
|
July 25, 2020
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study
Filippo Milano, Jonathan A Gutman, H Joachim Deeg, et al.
Transplantation and Cellular Therapy
|
October 13, 2021
Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage
Corinne Summers, Qian Vicky Wu, Colleen Annesley, et al.
JCO Clinical Cancer Informatics
|
January 30, 2026
Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration
Yimei Li, Yang Qiao, Fei Gao, et al.
JCO Clinical Cancer Informatics
|
April 20, 2026
Erratum: Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration
Yimei Li, Yang Qiao, Fei Gao, et al.
Transplantation and Cellular Therapy
|
May 21, 2025
Low Peripheral Blood Counts and Elevated Proinflammatory Cytokines Signal a Poor CD19 Chimeric Antigen Receptor T-cell Response in Acute Lymphoblastic Leukemia
Katelyn Burleigh, Kelly G Stratton, Jenny L Smith, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Journal for Immunotherapy of Cancer
|
November 19, 2025
CD28 signaling complexes are correlated with patient outcomes in anti-CD19 41BB-costimulation CAR T cell therapy
Isabella H Draper, William Selke, Samuel A Ritmeester-Loy, et al.
Transplantation and Cellular Therapy
|
September 9, 2023
INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia
Adam J Lamble, Amy Moskop, Michael A Pulsipher, et al.
Bone Marrow Transplantation
|
January 24, 2019
Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children
Ann Dahlberg, Wendy Leisenring, Marie Bleakley, et al.
Cancers
|
May 28, 2025
Disease Burden at the Time of Transplantation Is a Primary Predictor of Outcomes in Pediatric MDS: A Single-Center Experience
Ann Dahlberg, Phil Stevenson, Neel S Bhatt, et al.
JPGN Reports
|
May 11, 2023
Adjunctive Dietary Therapy Is Associated With Improved Gastrointestinal Symptoms in Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease: A Case Series
Tanyaporn Kaenkumchorn, David L Suskind, Dale Lee, et al.
Blood Advances
|
July 25, 2020
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study
Filippo Milano, Jonathan A Gutman, H Joachim Deeg, et al.
Transplantation and Cellular Therapy
|
October 13, 2021
Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage
Corinne Summers, Qian Vicky Wu, Colleen Annesley, et al.
JCO Clinical Cancer Informatics
|
January 30, 2026
Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration
Yimei Li, Yang Qiao, Fei Gao, et al.
JCO Clinical Cancer Informatics
|
April 20, 2026
Erratum: Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration
Yimei Li, Yang Qiao, Fei Gao, et al.
Transplantation and Cellular Therapy
|
May 21, 2025
Low Peripheral Blood Counts and Elevated Proinflammatory Cytokines Signal a Poor CD19 Chimeric Antigen Receptor T-cell Response in Acute Lymphoblastic Leukemia
Katelyn Burleigh, Kelly G Stratton, Jenny L Smith, et al.
Page
of 4